2022-RA-757-ESGO Bioimpedance screening for cervical cancer

نویسندگان

چکیده

Introduction/Background The pathological changes at different severity stages of cervical intraepithelial neoplasia (CIN) can give rise to the differences in electrical properties tissues, which lay foundation for screening CIN using non-invasive and cost-effective technique bioimpedance as well paves way easy availability screening, especially developing countries thereby reduction occurrence cancer. Methodology complex impedance measurements collected by a multi-electrode probe from clinically diagnosed 117 normal subjects, 18 subjects with low-grade squamous lesion (LSIL), 19 high-grade (HSIL) have been fitted Cole-Cole model, is used characterize biological tissues. geometrical features extracted model later exploited classify conditions tissues receiver operating characteristic (ROC) curve based on three algorithms: logistic regression, support vector machine, Naive Bayes. Results Regardless algorithms being used, area under (AUC) obtained apparently higher than that real part only, ROC areas between LSIL are much more improved when exploited, shown figure 2. Furthermore, due significant discrepancy HSIL cervix, greater AUC be observed separation irrespective used. Conclusion Compared utilization only measurements, our results present superior performance combination improving effectiveness classification during according analysis.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Electrical Bioimpedance Analysis: A New Method in Cervical Cancer Screening

Cervical cancer is the second most common female cancer worldwide and a disease of concern due to its high rate of incidence of about 500,000 women annually and is responsible for about 280,000 deaths in a year. The mortality and morbidity of cervical cancer are reduced through mass screening via Pap smear, but this technique suffers from very high false negativity of around 30% to 40% and henc...

متن کامل

ESGO statement on cervical cancer vaccination.

In 2004, almost 31,000 women in the EU25 were diagnosed with cervical cancer and 14,000 died from the disease. Assuming that the proportion of uterine cancer of cervical origin in the 12 countries not belonging to the European Economic Area was similar to that in the ten new European Union (EU) member states brings us to a rough estimate of 52,000 cases and 27,000 deaths for the whole European ...

متن کامل

Screening for cervical cancer and precancerous lesions in Tabriz

 Abstract Background: Cervical cancer is the most common female genital tract malignancy and is the major cause of death from gynecologic cancer worldwide. The majority of cervical cancers develop through a series of gradual, precancerous lesions. Screening asymptomatic women with regular Pap smears allows diagnosis of the readily treatable preinvasive phase. We performed this study to determin...

متن کامل

Screening for Cervical Cancer

February 2004 Vol.22 No.2 CME 63 Cervical cancer remains a major health concern worldwide, especially in developing countries. It is the commonest malignancy among black women in South Africa. The quoted incidence of cervical cancer is approximately 30/100 000 women. Mortality is higher in developing countries, mainly due to the lack of availability of screening and late-stage presentation. Cer...

متن کامل

Screening for Cervical Cancer

February 2004 Vol.22 No.2 CME 63 Cervical cancer remains a major health concern worldwide, especially in developing countries. It is the commonest malignancy among black women in South Africa. The quoted incidence of cervical cancer is approximately 30/100 000 women. Mortality is higher in developing countries, mainly due to the lack of availability of screening and late-stage presentation. Cer...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Diagnostics

سال: 2022

ISSN: ['2075-4418']

DOI: https://doi.org/10.1136/ijgc-2022-esgo.159